6-(Pyridin-3-yl)pyridazin-3(2H)-one hydrochloride

Catalog No.: 
ACCQIS018
CAS No.: 
2059941-42-1
Molecular Formula: 
C9H8ClN3O
Molecular Weight: 
209.64
6-(Pyridin-3-yl)pyridazin-3(2H)-one hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$76.00In stockInquiry
1g98%$194.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-(Pyridin-3-yl)pyridazin-3(2H)-one hydrochloride
IUPAC Name6-(pyridin-3-yl)pyridazin-3(2H)-one hydrochloride
MDL No.MFCD30497698
Molecular FormulaC9H8ClN3O
Molecular Weight209.64
SMILESO=C1C=CC(C2=CC=CN=C2)=NN1.[H]Cl
InChI KeyDRXYPRVMTOPRIE-UHFFFAOYSA-N
Synonym6-(Pyridin-3-yl)-2,3-dihydropyridazin-3-one hydrochloride;6-(pyridin-3-yl)pyridazin-3(2H)-one hydrochloride
CAS No.2059941-42-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACCQIS018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACEHMF832 route compound structure diagram
    ACEHMF83219064-67-6In Stock
  2. Plus
  3. ACPGVQ689 route compound structure diagram
    ACPGVQ6891692-25-7In Stock
  4. Then
  5. ACCQIS018 route product structure diagram
    ACCQIS0182059941-42-1In Stock
Inquiry

2. ACCQIS018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCQIS018 route product structure diagram
    ACCQIS0182059941-42-1In Stock
Inquiry

3. ACCQIS018 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACCQIS018 route product structure diagram
    ACCQIS0182059941-42-1In Stock
Inquiry

Comments (0)